Lista de obras - Mario Losen - Dominio Público Uruguay

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.

artículo científico publicado en 2013

A novel method for making human monoclonal antibodies.

artículo científico publicado en 2010

Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

artículo científico publicado en 2007

Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction

artículo científico publicado en 2010

Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders

artículo científico publicado en 2013

Autoantigen induced clonal expansion in immortalized B cells from the peripheral blood of multiple sclerosis patients

artículo científico publicado en 2013

B cell characterization and reactivity analysis in multiple sclerosis

artículo científico publicado en 2009

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient.

artículo científico publicado en 2017

Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor

artículo científico publicado en 2014

Complement activation by ceramide transporter proteins

artículo científico publicado en 2014

DGAT1 overexpression in muscle by in vivo DNA electroporation increases intramyocellular lipid content

artículo científico publicado en 2004

Effect of oxygen limitation and medium composition on Escherichia coli fermentation in shake-flask cultures

artículo científico publicado en 2004

Effect of oxygen supply on passaging, stabilising and screening of recombinant Hansenula polymorpha production strains in test tube cultures

artículo científico publicado en 2003

Erratum: gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

artículo científico publicado en 2011

Familial occurrence of autoimmune myasthenia gravis with different antibody specificity

scientific article published on 01 May 2008

Gene-environment interaction research and transgenic mouse models of Alzheimer's disease

artículo científico publicado en 2010

Generation of polyclonal antibodies directed against G protein-coupled receptors using electroporation-aided DNA immunization

artículo científico publicado en 2008

Glycine receptor antibodies in PERM: a new channelopathy

artículo científico publicado en 2014

Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques

artículo científico publicado en 2012

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.

artículo científico publicado en 2014

Guidelines for pre-clinical assessment of the acetylcholine receptor--specific passive transfer myasthenia gravis model-Recommendations for methods and experimental designs

artículo científico publicado en 2015

Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys

artículo científico publicado en 2017

Immunoregulation in experimental autoimmune myasthenia gravis--about T cells, antibodies, and endplates

artículo científico publicado en 2003

Immunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil.

artículo científico publicado en 2008

In vivo electroporation of the central nervous system: a non-viral approach for targeted gene delivery

scientific article published on 16 October 2010

Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis

artículo científico publicado en 2005

Low Current-driven Micro-electroporation Allows Efficient In Vivo Delivery of Nonviral DNA into the Adult Mouse Brain

artículo científico publicado en 2008

Low prevalence of Merkel cell polyomavirus in human epithelial thymic tumors

artículo científico publicado en 2019

Main Immunogenic Region Structure Promotes Binding of Conformation-Dependent Myasthenia Gravis Autoantibodies, Nicotinic Acetylcholine Receptor Conformation Maturation, and Agonist Sensitivity

artículo científico publicado en 2009

MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.

scientific article published on 02 December 2013

MuSK myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient.

artículo científico publicado en 2012

Muscle disuse atrophy is not accompanied by changes in skeletal muscle satellite cell content.

artículo científico publicado en 2014

Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice

artículo científico publicado en 2012

Neuropathy-induced spinal GAP-43 expression is not a main player in the onset of mechanical pain hypersensitivity

artículo científico publicado en 2011

Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety

artículo científico publicado en 2020

Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis

artículo científico publicado en 2007

Paradoxical increase in TAG and DAG content parallel the insulin sensitizing effect of unilateral DGAT1 overexpression in rat skeletal muscle

artículo científico publicado en 2011

Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4.

artículo científico

Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis.

artículo científico publicado en 2011

Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients

artículo científico publicado en 2014

Proteomic analysis of rat tibialis anterior muscles at different stages of experimental autoimmune myasthenia gravis.

artículo científico publicado en 2013

Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis.

artículo científico publicado en 2010

Silencing rapsyn in vivo decreases acetylcholine receptors and augments sodium channels and secondary postsynaptic membrane folding

scientific journal article

Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs

artículo científico publicado en 2015

Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?

artículo científico publicado en 2012

The auto-antigen repertoire in myasthenia gravis.

scientific article published on August 2010

The ceramide transporter and the Goodpasture antigen binding protein: one protein--one function?

artículo científico publicado en 2010

The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates

artículo científico publicado en 2009

The expression of the Goodpasture antigen-binding protein (ceramide transporter) in adult rat brain

artículo científico publicado en 2009

The lipid droplet coat protein perilipin 5 also localizes to muscle mitochondria

scientific journal article

Treatment of myasthenia gravis by preventing acetylcholine receptor modulation

artículo científico publicado en 2008

Unchanged expression of the ceramide transfer protein in the acute 6-OHDA neurodegenerative model

artículo científico publicado en 2012

Lista de obras de Mario Losen

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.

A novel method for making human monoclonal antibodies.

Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction

Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders

Autoantigen induced clonal expansion in immortalized B cells from the peripheral blood of multiple sclerosis patients

B cell characterization and reactivity analysis in multiple sclerosis

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient.

Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor

Complement activation by ceramide transporter proteins

DGAT1 overexpression in muscle by in vivo DNA electroporation increases intramyocellular lipid content

Effect of oxygen limitation and medium composition on Escherichia coli fermentation in shake-flask cultures

Effect of oxygen supply on passaging, stabilising and screening of recombinant Hansenula polymorpha production strains in test tube cultures

Erratum: gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

Familial occurrence of autoimmune myasthenia gravis with different antibody specificity

Gene-environment interaction research and transgenic mouse models of Alzheimer's disease

Generation of polyclonal antibodies directed against G protein-coupled receptors using electroporation-aided DNA immunization

Glycine receptor antibodies in PERM: a new channelopathy

Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.

Guidelines for pre-clinical assessment of the acetylcholine receptor--specific passive transfer myasthenia gravis model-Recommendations for methods and experimental designs

Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys

Immunoregulation in experimental autoimmune myasthenia gravis--about T cells, antibodies, and endplates

Immunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil.

In vivo electroporation of the central nervous system: a non-viral approach for targeted gene delivery

Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis

Low Current-driven Micro-electroporation Allows Efficient In Vivo Delivery of Nonviral DNA into the Adult Mouse Brain

Low prevalence of Merkel cell polyomavirus in human epithelial thymic tumors

Main Immunogenic Region Structure Promotes Binding of Conformation-Dependent Myasthenia Gravis Autoantibodies, Nicotinic Acetylcholine Receptor Conformation Maturation, and Agonist Sensitivity

MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.

MuSK myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient.

Muscle disuse atrophy is not accompanied by changes in skeletal muscle satellite cell content.

Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice

Neuropathy-induced spinal GAP-43 expression is not a main player in the onset of mechanical pain hypersensitivity

Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety

Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis

Paradoxical increase in TAG and DAG content parallel the insulin sensitizing effect of unilateral DGAT1 overexpression in rat skeletal muscle

Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4.

Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis.

Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients

Proteomic analysis of rat tibialis anterior muscles at different stages of experimental autoimmune myasthenia gravis.

Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis.

Silencing rapsyn in vivo decreases acetylcholine receptors and augments sodium channels and secondary postsynaptic membrane folding

Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs

Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?

The auto-antigen repertoire in myasthenia gravis.

The ceramide transporter and the Goodpasture antigen binding protein: one protein--one function?

The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates

The expression of the Goodpasture antigen-binding protein (ceramide transporter) in adult rat brain

The lipid droplet coat protein perilipin 5 also localizes to muscle mitochondria

Treatment of myasthenia gravis by preventing acetylcholine receptor modulation

Unchanged expression of the ceramide transfer protein in the acute 6-OHDA neurodegenerative model